#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14116	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2264	619.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1706	1706	T	742	T,C,G	574,103,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14116	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2264	619.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1440	1440	C	811	C	756	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25210	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	694.7	0	.	n	.	0	T665C	SNP	665	665	T	999	999	C	722	C,T	598,78	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25210	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	694.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1671	1671	A	827	A,G	778,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25210	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	694.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2305	2305	C	794	C	731	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25210	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	694.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2379	2379	A	789	A	741	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25210	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3618	694.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2931	2931	C	778	C	730	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	155	1890	folP	852	852	99.88	folP.l15.c30.ctg.1	1411	132.8	0	HET	.	.	.	C225CGAAGAAGAA,CGAAGAAGAAGAA	.	225	225	C	508	508	C	194	CGAAGAAGAA,CGAAGAAGAAGAA	139,23	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	5210	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3466	149.8	1	SNP	p	S91F	0	.	.	271	273	TCC	629	631	TCC	201;199;199	T;C,T;C	188;163,24;187	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	5210	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3466	149.8	1	SNP	p	D95G	0	.	.	283	285	GAC	641	643	GAC	202;202;203	G;A,G;C,T	189;165,23;184,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	5210	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3466	149.8	1	SNP	p	D95N	0	.	.	283	285	GAC	641	643	GAC	202;202;203	G;A,G;C,T	189;165,23;184,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	5210	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3466	149.8	0	HET	.	.	.	T744C	.	744	744	T	1102	1102	T	153	T,C	118,25	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	667	1672	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1509	110.4	0	.	p	.	0	D79N	NONSYN	235	237	GAT	637	639	AAT	205;204;204	A,G;A;T	158,36;193;191	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	667	1672	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1509	110.4	1	SNP	p	G45D	0	.	.	133	135	GGC	535	537	GGC	203;205;206	G;G;C	182;184;184	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	667	1672	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1509	110.4	0	HET	.	.	.	C181T	.	181	181	C	583	583	C	205	C,T	162,27	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	667	1672	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1509	110.4	0	HET	.	.	.	G249T	.	249	249	G	651	651	G	206	G,T	158,35	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	667	1672	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1509	110.4	0	HET	.	.	.	G256A	.	256	256	G	658	658	G	201	G,A	156,30	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	667	1672	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1509	110.4	0	HET	.	.	.	T141C	.	141	141	T	543	543	T	199	T,C	156,28	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	667	1672	mtrR	633	633	99.84	mtrR.l6.c30.ctg.1	1509	110.4	0	HET	.	.	.	C174T	.	174	174	C	576	576	C	208	C,T	162,29	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	808	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	1049	76.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1535	1537	ATC	181;182;182	A,G;T;C	145,26;173;169	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1688	1690	GCA	187;185;184	G;C,T,G;A,G	171;141,22,1;143,22	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2171	2173	ATT	190;191;190	A,G;T;T	147,24;173;175	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	1	SNP	p	D86N	0	.	.	256	258	GAC	641	643	GAC	179;178;177	G;A;C	166;163;162	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	1	SNP	p	S87I	0	.	.	259	261	AGT	644	646	AGT	178;180;180	A,C;G;T	136,28;165;165	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	1	SNP	p	S87R	0	.	.	259	261	AGT	644	646	AGT	178;180;180	A,C;G;T	136,28;165;165	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	1	SNP	p	S87W	0	.	.	259	261	AGT	644	646	AGT	178;180;180	A,C;G;T	136,28;165;165	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	1	SNP	p	S88P	0	.	.	262	264	TCC	647	649	TCC	183;182;181	T;C;C	167;166;168	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	HET	.	.	.	T903C	.	903	903	T	1288	1288	T	196	T,C	155,28	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	HET	.	.	.	C876T	.	876	876	C	1261	1261	C	202	C,T	160,26	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	HET	.	.	.	G879A	.	879	879	G	1264	1264	G	200	G,A	160,27	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	HET	.	.	.	T1431C	.	1431	1431	T	1816	1816	T	218	T,C	170,36	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	HET	.	.	.	T312C	.	312	312	T	697	697	T	182	T,C	134,26	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	HET	.	.	.	T1435C	.	1435	1435	T	1820	1820	T	224	T,C	170,38	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	667	4800	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2947	162.1	0	HET	.	.	.	G990C	.	990	990	G	1375	1375	G	186	G,C	140,28	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	155	4152	parE	1986	1986	99.95	parE.l6.c30.ctg.1	2738	151.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1619	1621	GGC	203;203;200	G;G;C	191;190;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1056	1058	GCA	227;227;227	G;C;A	210;211;210	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1059	1061	ATC	227;227;230	A;T;C	209;212;213	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1071	1073	GTG	215;216;214	G;T;G	201;203;200	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1071	1073	GTG	215;216;214	G;T;G	201;203;200	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1575	1577	ACC	200;197;199	A;C;C,A,T	189;187;190,1,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1629	1631	GCG	183;181;179	G;C;G	166;155;158	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1629	1631	GCG	183;181;179	G;C;G	166;155;158	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1752	1754	GGT	176;173;170	G,A;G;T,C	143,15;158;137,15	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1761	1763	GGC	176;174;174	G;G;C	158;158;156	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1779	1781	CCG	164;167;167	C;C;G	129;143;131	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	G1572C	.	1572	1572	G	1697	1697	G	201	G,C	156,29	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	G1669A	.	1669	1669	G	1794	1794	G	173	G,A	126,23	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	T1575C	.	1575	1575	T	1700	1700	T	202	T,C	155,29	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	C1671T	.	1671	1671	C	1796	1796	C	174	C,T	127,20	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	T1581C	.	1581	1581	T	1706	1706	T	192	T,C	152,24	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	A1584C	.	1584	1584	A	1709	1709	A	193	A,C	155,24	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	C1666A	.	1666	1666	C	1791	1791	C	171	C,A	123,23	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	C1587T	.	1587	1587	C	1712	1712	C	198	C,T	162,23	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	T1653G	.	1653	1653	T	1778	1778	T	160	T,G	102,26	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	C1599G	.	1599	1599	C	1724	1724	C	191	C,G	155,22	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	T1569C	.	1569	1569	T	1694	1694	T	204	T,C	158,28	.	.
penA.22.001	penA.22.001	1	1	155	3824	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2039	183.3	0	HET	.	.	.	T1602A	.	1602	1602	T	1727	1727	T	188	T,A	152,21	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	155	5384	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3138	171.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1612	1614	CTG	182;186;187	C;T,C;G	161;143,26;169	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	659	2114	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1830	115.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	585	585	C	168	C	156	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	A29V	NONSYN	85	87	GCC	448	450	GTC	186;185;188	G;T,C;C	170;157,4;172	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	G41R	NONSYN	121	123	GGA	484	486	AGA	193;192;189	A;G;A	174;174;169	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	T50A	NONSYN	148	150	ACT	511	513	GCT	188;190;193	G;C,G;T,C	172;173,1;175,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	K88L	NONSYN	262	264	AAA	625	627	CTC	157;154;151	C;T;C	153;147;145	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	S93N	NONSYN	277	279	AGC	640	642	AAC	149;149;147	A;A;C	137;137;136	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	H111R	NONSYN	331	333	CAT	694	696	CGT	168;169;168	C;G;T	160;164;163	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	N114S	NONSYN	340	342	AAC	703	705	AGC	165;165;164	A;G;C,T	158;158;159,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	I115V	NONSYN	343	345	ATC	706	708	GTC	166;166;168	G;T;C	159;158;162	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	D120G	NONSYN	358	360	GAC	721	723	GGC	169;169;170	G;G;C	160;159;160	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	Y201F	NONSYN	601	603	TAC	964	966	TTC	193;192;194	T;T;C	177;175;179	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2224	porB1a	984	984	98.37	porB1a.l15.c17.ctg.1	1491	148.2	0	.	p	.	0	S236R	NONSYN	706	708	AGC	1069	1071	CGC	206;204;205	C;G;C	192;189;191	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.2	1195	27.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	152	154	GAA	29;29;29	G;A;A	27;28;28	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.2	1195	27.7	0	.	p	.	0	T119A	NONSYN	355	357	ACC	395	397	GCC	24;25;26	G;C;C	21;22;24	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.2	1195	27.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	440	442	GAT	31;32;32	G;A;T	30;31;30	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.2	1195	27.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	563	565	TCA	32;32;31	T;C;A	28;30;29	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.2	1195	27.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	692	694	GTC	30;29;29	G;T;C	27;25;27	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.2	1195	27.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1022	1024	GCA	35;35;34	G;C;A	33;32;32	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.2	1195	27.7	1	SNP	p	G120K	1	.	.	358	360	AAG	398	400	AAG	27;27;27	A;A;G	25;24;25	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.2	1195	27.7	1	SNP	p	D121N	0	.	.	361	363	GAC	401	403	GAC	28;27;27	G;A;C	25;25;24	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	656	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.2	1195	27.7	1	SNP	p	A121D	1	.	.	361	363	GAC	401	403	GAC	28;27;27	G;A;C	25;25;24	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	155	10248	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4800	212.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1904	1906	CAT	206;204;204	C;A;T	197;195;194	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	155	1140	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1045	108.5	1	SNP	p	V57M	0	.	.	169	171	GTG	478	480	GTG	248;251;253	G,A;T;G	208,27;240;239	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
